Skip to main content

BRS1 — Neurotransmitter Regulation

BRS1(FM1) - Catecholaminergic Function (Dopamine + Norepinephrine)

1. Definition

Provision and brain-delivery context of catecholamine precursors and signalling support for dopamine- and norepinephrine-related motivation, attention, arousal, and executive function.

2. Functional Outcome Context

These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. Confidence may increase where multiple child PMs converge on the same functional outcome.

No functional outcome context currently mapped.

3. Intervention Breakdown

Food-State Leaning

4. Functional Role

↑ precursor availability; ↑ tyrosine/tryptophan support; improved brain-delivery context

5. Mechanistic Basis (Integrated FM Narrative)

Catecholaminergic function emerges from the coordinated interaction of several primary mechanisms and supporting biological pools.

5.1 Core Primary Mechanisms

5.2 Supporting Biological Pools (Key Constraints)

5.3 Integrated Functional Narrative

Together, these PMs operationalise BRS1(FM1) as coordinated meal-level control of catecholaminergic and related neurotransmitter signalling.

5.4 Functional Failure Modes

Catecholaminergic function may weaken when amino acid quality & competitive balance declines or when reliance on incomplete protein sources without complementary pairing.

Reliance on incomplete protein sources without complementary pairing may reduce BRS1(KC2) — Amino Acid Quality & Competitive Balance. Chronically low indispensable amino-acid coverage across meals may further strain pool availability, lNAA imbalance favouring transport competition away from key precursors, ultra-processed low-protein dietary patterns, while inconsistent protein distribution across the day.

These pressures may impair BRS1-FM1-PM1 — Amino-Acid Availability & Prioritisation, weaken BRS1-FM2-PM3 — LAT1 Competitive Transport Modulation, and reduce the effectiveness of BRS1-FM1-PM2 — Noradrenergic Signalling (Attention & Executive Modulation). At the FM level, this may shift BRS1(FM1) toward reduced catecholaminergic function performance.

6. Connected Mechanisms

  • None listed

7. References

  1. Wurtman et al. (2003)
  2. Fernstrom (2013)